Clinical Trials Directory

Trials / Terminated

TerminatedNCT03676543

Mutual Interactions Between Absence Epilepsy Seizures and the Integration of Sensory Stimuli

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
1 (actual)
Sponsor
Fondation Ophtalmologique Adolphe de Rothschild · Network
Sex
All
Age
2 Years – 21 Years
Healthy volunteers
Not accepted

Summary

Epileptic seizures arise from neuronal defects that often alter the capacity of the brain to process sensory information. During absence seizures, a frequent epileptic syndrome in children, the normal conscious and perceptual processes are temporarily interrupted. This is the result of abnormal synchronized neural activities in the thalamo-cortical loops, leading to bilateral spike-and-wave discharges (SWDs) in the cortical electroencephalograms (EEGs). The brain mechanisms underlying the lack of sensory experience during absence seizures are disputed. Based on preliminary data, the investigators hypothesize that the alternation of 'spike' and 'wave' patterns during seizure could cause a time-to-time inconstancy in cortical responsiveness, preventing conscious perception. Using a real-time closed-loop stimulation system, the investigators will research how the S- and W-patterns specifically alter the sensory-evoked responses in the EEG. During a standard EEG, visual stimulations will be applied between and during absence seizures to test the hypothesis that repeated sensory stimuli, applied with an appropriate timing relative to the seizure-related oscillatory cycle, could negatively interfere with the regenerative network mechanisms involved in the occurrence of SWDs. The completion of this project should permit to unveil a new neuronal mechanism supporting the lack of conscious experience during absences and pave the way for new clinical non-invasive strategies to interrupt ongoing seizure activity.

Conditions

Interventions

TypeNameDescription
PROCEDURETimed repetitive sensory stimulationTimed repetitive sensory stimulation (TRSS) will be applied at the onset or during seizures

Timeline

Start date
2018-06-07
Primary completion
2022-08-29
Completion
2022-08-29
First posted
2018-09-18
Last updated
2022-09-21

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03676543. Inclusion in this directory is not an endorsement.